🇺🇸 FDA
Pipeline program

DOTAREM 0,5 mmol/mL, solution injectable, GADOPICLENOL

GDX-102/GDX-44-017

Phase 3 small_molecule active

Quick answer

DOTAREM 0,5 mmol/mL, solution injectable, GADOPICLENOL for Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar), peripheral or abdominal/renal arteries is a Phase 3 program (small_molecule) at Guerbet with 1 ClinicalTrials.gov record(s).

Program details

Company
Guerbet
Indication
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar), peripheral or abdominal/renal arteries
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials